U.S. FDA Approves NEXTSTELLIS®, New Oral Contraceptive
GREENVILLE, N.C., April 16, 2021 /PRNewswire/ --Â Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved NEXTSTELLIS (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) for the prevention of pregnancy. NEXTSTELLIS is the first and only contraceptive pill containing E4, a naturally occurring estrogen, now produced from a plant source, with a unique mechanism of action that offers potential advantages over other estrogens. "When speaking with patient...
Source: johnsoncitypress.com